Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Expression Profiles Define Microbial Infection

By LabMedica International staff writers
Posted on 08 Aug 2013
A molecular test distinguishes between viral and bacterial infections in children with fever by profiling the activity of genes in a blood sample.

In febrile children, it is difficult to know whether the child has a viral infection that will resolve on its own or a potentially serious bacterial infection that requires antibiotics. More...


Scientists at Washington University School of Medicine (St. Louis, MO, USA) can distinguish between viral and bacterial infections in children with fever by profiling the activity of genes in white blood cells. They studied 30 children ages two months to three years who had fevers above 38 °C, but no obvious signs of illness, like a cough or diarrhea. Twenty-two of the children were known to have viral infections based on previous extensive genomic testing that is not yet practical to use in a clinic setting, and eight others children had bacterial infections.

The investigators used a test called a gene expression microarray that could identify patterns of gene activity in white blood cells and could discriminate children with viral infections from those with bacterial infections. In addition to whole-blood and nasopharyngeal samples for virus specific polymerase chain reaction (PCR) and high-throughput sequencing, a blood sample was collected in a Tempus Blood Ribonucleic Acid (RNA) Tube (Applied Biosystems, Foster City, CA, USA; www.appliedbiosystems.com) and stored at -80 °C for subsequent gene expression analysis.


The microarray technology enabled the team to easily distinguish bacterial infections from viral infections based on distinctive patterns of gene expression. As a comparison, the scientists performed the microarray analysis on blood samples from 35 children without fever, also ages two months to three years, who were having outpatient surgery. Earlier genomic testing showed that eight of those children had viruses, even though they did not cause any symptoms.

Gregory A. Storch, MD, a professor of pediatrics and senior author of the study said, “In the kids with a virus and a fever, many genes were very active, compared with kids who had viruses and no fever, whose genes were quiet. The microarray basically tells us how a patient is reading the infection. The very active genes tell us that an infection is making a patient sick, while quiet genes tell us either there's no infection or maybe a bacterium or virus is there, but it's not causing fever or illness.” The potential benefit of using tests that measures the response of genes to get more conclusive answers to illness. This would help to ensure that antibiotics are targeted to those children who really need them. The study was published on July 15. 2013, in the Proceedings of the National Academy of Science of the United States of America (PNAS).

Related Links:

Washington University School of Medicine

Applied Biosystems



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.